NCT00667563 2024-03-19Vaccine Therapy in Preventing HPV in HIV-Positive Women in IndiaAIDS Malignancy ConsortiumPhase 1 Completed150 enrolled 12 charts
NCT03912831 2023-12-26Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ CancersGilead SciencesPhase 1 Terminated8 enrolled 13 charts
NCT00541970 2018-08-17Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 YrsGlaxoSmithKlinePhase 1 Completed961 enrolled 43 charts
NCT00549900 2018-07-20A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese FemalesGlaxoSmithKlinePhase 1 Completed30 enrolled 10 charts
NCT00635830 2015-10-09An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)Merck Sharp & Dohme LLCPhase 1 Completed40 enrolled 7 charts